BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30954326)

  • 1. Corrigendum to "Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population" [Eur. J. Radiol. 110 (2019) 130-135].
    Kamitani T; Yabuuchi H; Kanemaki Y; Tozaki M; Sonomura T; Mizukoshi W; Nakata W; Shimono T; Urano M; Yamano T; Kato F; Kuchiki M; Shiraga N; Yanagita H; Katsuda E; Kataoka M; Yamaguchi K; Horikoshi T; Gomi T; Nozaki M; Shiotani M; Amano M; Saigusa H; Sadaoka S; Kamiya H; Kubo M; Yamashita N; Yamamoto H; Honda H
    Eur J Radiol; 2019 May; 114():192. PubMed ID: 30954326
    [No Abstract]   [Full Text] [Related]  

  • 2. Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition.
    Kang SS; Ko EY; Han BK; Shin JH; Hahn SY; Ko ES
    J Magn Reson Imaging; 2014 Mar; 39(3):526-34. PubMed ID: 23633296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast.
    Müller-Schimpfle M; Ohmenhaüser K; Stoll P; Dietz K; Claussen CD
    Radiology; 1997 Apr; 203(1):145-9. PubMed ID: 9122383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer: A meta-analysis" [Eur. J. Radiol. 168 (2023) 111127].
    Ma Q; Li Z; Li W; Chen Q; Liu X; Feng W; Lei J
    Eur J Radiol; 2024 Jan; 170():111226. PubMed ID: 38056346
    [No Abstract]   [Full Text] [Related]  

  • 5. [MR-imaging of the breast at 0.5 Tesla: menstrual-cycle dependency of parenchymal contrast enhancement in healthy volunteers with oral contraceptive use?].
    Lorenzen J; Welger J; Lisboa BW; Krupski G; Adam G
    Rofo; 2003 Apr; 175(4):502-6. PubMed ID: 12677505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Preoperative breast cancer staging with multi-modality imaging and surgical outcomes" [Eur. J. Radiol. 122 (2020) 108766].
    Mariscotti G; Durando M; Tagliafico A; Campanino PP; Bosco D; Casella C; Bussone R; Ala A; Castellano I; Sapino A; Bergamasco L; Fonio P; Houssami N
    Eur J Radiol; 2020 May; 126():108919. PubMed ID: 32197783
    [No Abstract]   [Full Text] [Related]  

  • 7. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle.
    Uematsu T; Kasami M; Watanabe J
    Eur J Radiol; 2012 Jul; 81(7):1539-42. PubMed ID: 21592704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Improving contrast enhancement in pulmonary CTA: The value of breathing maneuvers" [Eur J Radiol Open 7 (2020) 100280].
    Manava P; Galster M; Schoen M; Ficker J; Lell MM; Adamus R; Bruch M
    Eur J Radiol Open; 2021; 8():100356. PubMed ID: 34041308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX" [Eur. J. Radiol. 143 (2021) 109887].
    Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
    Eur J Radiol; 2022 Mar; 148():110154. PubMed ID: 35016131
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "3T MRI in paediatrics: Challenges and clinical applications" [Eur. J. Radiol. 68 (2) (2008) 309-319].
    Dagia C; Ditchfield M
    Eur J Radiol; 2014 Dec; 83(12):2294. PubMed ID: 28859936
    [No Abstract]   [Full Text] [Related]  

  • 11. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue.
    Delille JP; Slanetz PJ; Yeh ED; Kopans DB; Garrido L
    Breast J; 2005; 11(4):236-41. PubMed ID: 15982388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.
    DeLeo MJ; Domchek SM; Kontos D; Conant E; Chen J; Weinstein S
    AJR Am J Roentgenol; 2015 Mar; 204(3):669-73. PubMed ID: 25714301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum to "Non-palpable incidentally found testicular tumors: Differentiation between benign, malignant, and burned-out tumors using dynamic contrast-enhanced MRI" [Eur. J. Radiol. 85(11) (2016) 2072-2082].
    El Sanharawi I; Correas JM; Glas L; Ferlicot S; Izard V; Ducot B; Bellin MF; Benoît G; Rocher L
    Eur J Radiol; 2017 Mar; 88():171. PubMed ID: 28069337
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
    Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
    Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of menstrual cycle and menopausal status on apparent diffusion coefficient values and detectability of invasive ductal carcinoma on diffusion-weighted MRI.
    Shin S; Ko ES; Kim RB; Han BK; Nam SJ; Shin JH; Hahn SY
    Breast Cancer Res Treat; 2015 Feb; 149(3):751-9. PubMed ID: 25638396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementation" [Eur. J. Radiol. 167 (2023) 111087].
    van Nijnatten TJA; Payne NR; Hickman SE; Ashrafian H; Gilbert FJ
    Eur J Radiol; 2024 Jan; 170():111202. PubMed ID: 37988959
    [No Abstract]   [Full Text] [Related]  

  • 17. Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study.
    Wang J; Kato F; Oyama-Manabe N; Li R; Cui Y; Tha KK; Yamashita H; Kudo K; Shirato H
    PLoS One; 2015; 10(11):e0143308. PubMed ID: 26600392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Evaluation of breast cancer malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model" [Eur. J. Radiol. 166 (2023) 111003].
    Chang H; Wang D; Li Y; Xiang S; Yang YX; Kong P; Fang C; Ming L; Wang X; Zhang C; Jia W; Yan Q; Liu X; Zeng Q
    Eur J Radiol; 2023 Dec; 169():111158. PubMed ID: 37897958
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer.
    van der Velden BH; Dmitriev I; Loo CE; Pijnappel RM; Gilhuijs KG
    Radiology; 2015 Sep; 276(3):675-85. PubMed ID: 25811614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
    Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
    Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.